Omnicell (OMCL) Misses Q2 EPS by 2c; Maintains Outlook

Omnicell (NASDAQ: OMCL) reported Q2 EPS of $0.84, $0.02 worse than the analyst estimate of $0.86. Revenue for the quarter came in at $331 million versus the consensus estimate of $339.74 million.

GUIDANCE:

Omnicell maintains FY2022 EPS of $3.85-$4.05. Omnicell maintains FY2022 revenue of $1.385-1.41 million, versus the consensus of $1.4 million.

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Hormel Foods (HRL) Tops Q3 EPS by 2c, Misses on Revenue; Offers FY26 Guidance
• HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance